Gregory Pietz resumes & CV records
Resumes
Ncr-Iads Evaluator At Us Army, Test & Evaluation Command
Location:
United States
Industry:
Defense & Space
Gregory E Pietz, Age 5110508 1St Ave NW, Seattle, WA 98177
Gregory Pietz Phones & Addresses
10508 1St Ave NW, Seattle, WA 98177
Schofield, WI
330 Amoth Ct, Madison, WI 53704
Cleveland Heights, OH
Menomonee Falls, WI
Social networks
Gregory E Pietz
Linkedin
Industries
Defense & Space
Mentions for Gregory E Pietz
Publications & IP owners
Us Patents
Recombinant Production Of Polyanionic Polymers, And Uses Thereof
US Patent:
2005011, Jun 2, 2005
Filed:
Sep 14, 2004
Appl. No.:
10/939988
Inventors:
David Leung - Mercer Island WA, US
Philip Bergman - Mountlake Terrace WA, US
Alan Lofquist - Kirkland WA, US
Gregory Pietz - Seattle WA, US
Christopher Tompkins - Bothell WA, US
David Waggoner - Seattle WA, US
Philip Bergman - Mountlake Terrace WA, US
Alan Lofquist - Kirkland WA, US
Gregory Pietz - Seattle WA, US
Christopher Tompkins - Bothell WA, US
David Waggoner - Seattle WA, US
International Classification:
A61K038/20
A61K038/19
A61K038/21
A61K039/395
C07K014/535
C07K014/54
A61K038/19
A61K038/21
A61K039/395
C07K014/535
C07K014/54
US Classification:
424085100, 424085700, 530351000, 424130100
Abstract:
A polyanionic polymer can improve the bioactivity and water-solubility properties of a drug to which it is joined. The inventive method provides a monodispersed preparation of a recombinantly-produced polyanionic polymer that can be easily manipulated, such as lengthened. An active moiety may be chemically or recombinantly joined to a polyanionic polymer to increase its biological half-life and/or solubility. The instant invention also provides a method for targeting the delivery of a polyanionic polymer conjugate or fusion protein to a specific cell type or tissue.
Recombinant Production Of Polyanionic Polymers, And Uses Thereof
US Patent:
2008017, Jul 24, 2008
Filed:
Oct 30, 2007
Appl. No.:
11/928737
Inventors:
David W. Leung - Mercer Island WA, US
Philip A. Bergman - Mountlake Terrace WA, US
Alan Lofquist - Kirkland WA, US
Gregory E. Pietz - Seattle WA, US
Christopher K. Tompkins - Bothell WA, US
David W. Waggoner - Seattle WA, US
Philip A. Bergman - Mountlake Terrace WA, US
Alan Lofquist - Kirkland WA, US
Gregory E. Pietz - Seattle WA, US
Christopher K. Tompkins - Bothell WA, US
David W. Waggoner - Seattle WA, US
International Classification:
C12P 21/00
C07K 1/00
C07K 16/00
C12N 15/64
C07K 1/00
C07K 16/00
C12N 15/64
US Classification:
435 697, 530399, 530351, 5303871, 4353201
Abstract:
A polyanionic polymer can improve the bioactivity and water-solubility properties of a drug to which it is joined. The inventive method provides a monodispersed preparation of a recombinantly-produced polyanionic polymer that can be easily manipulated, such as lengthened. An active moiety may be chemically or recombinantly joined to a polyanionic polymer to increase its biological half-life and/or solubility. The instant invention also provides a method for targeting the delivery of a polyanionic polymer conjugate or fusion protein to a specific cell type or tissue.
Recombinant Production Of Polyanionic Polymers And Uses Thereof
US Patent:
2002016, Nov 14, 2002
Filed:
Mar 20, 2002
Appl. No.:
10/101487
Inventors:
David Leung - Mercer Island WA, US
Philip Bergman - Mountlake Terrace WA, US
Alan Lofquist - Kirkland WA, US
Gregory Pietz - Seattle WA, US
Christopher Tompkins - Bothell WA, US
David Waggoner - Seattle WA, US
Philip Bergman - Mountlake Terrace WA, US
Alan Lofquist - Kirkland WA, US
Gregory Pietz - Seattle WA, US
Christopher Tompkins - Bothell WA, US
David Waggoner - Seattle WA, US
Assignee:
CELL THERAPEUTICS, INC.
International Classification:
A61K038/17
A61K038/18
A61K038/19
A61K038/20
A61K038/21
A61K038/18
A61K038/19
A61K038/20
A61K038/21
US Classification:
514/012000, 424/085100, 424/085400, 424/085200, 530/350000, 530/351000, 530/399000, 435/069500, 435/069700
Abstract:
A polyanionic polymer can improve the bioactivity and water-solubility properties of a drug to which it is joined. The inventive method provides a monodispersed preparation of a recombinantly-produced polyanionic polymer that can be easily manipulated, such as lengthened. An active moiety may be chemically or recombinantly joined to a polyanionic polymer to increase its biological half-life and/or solubility. The instant invention also provides a method for targeting the delivery of a polyanionic polymer conjugate or fusion protein to a specific cell type or tissue.
NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.